Dow Down 0.17% Nasdaq Down 0.28%

Meridian Bioscience, Inc. (VIVO)

-NasdaqGS
17.69 Down 0.06(0.34%) Sep 30, 4:15PM EDT
|After Hours : 17.69 Up 0.00 (0.03%) Sep 30, 4:37PM EDT
Prev Close:17.75
Open:17.79
Bid:0.25 x 100
Ask:20.00 x 200
1y Target Est:20.29
Beta:1.51
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:17.62 - 18.18
52wk Range:17.52 - 27.72
Volume:307,747
Avg Vol (3m):248,803
Market Cap:735.32M
P/E (ttm):20.81
EPS (ttm):0.85
Div & Yield:0.80 (4.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for VIVO

Comparison

Symbol% ChgMkt Cap
VIVODown 0.34%735.32M
ABTDown 0.74%62.54B
BDXDown 0.47%21.83B

Key Statistics

Forward P/E (1 yr):19.23
P/S (ttm):3.87
Ex-Dividend Date:31-Jul-14

Analysts

Annual EPS Est (Sep-14) :0.86
Quarterly EPS Est (Sep-14) :0.22
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):1.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback